Gastrointestinal Delivery of APIs from Chitosan Nanoparticles
Successful clinical treatment outcomes rely on achieving optimal systemic delivery of therapeutics. The oral route of administering Active Pharmaceutical Ingredients (API) remains formidable because of ease to the patient and convenience. Yet, the gastrointestinal tract (GIT) poses several barriers...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2020
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/74561 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Gastrointestinal Delivery of APIs from Chitosan Nanoparticles
- Biomedical Potential of Chitosan Nanoparticles: Advances in Drug Delivery and Disease Management
- Nanoparticles Based on Chitosan Derivatives
- Chitosan Nanoparticle: Synthesis, Characterization, and Use as Plant Health Materials
- Chitosan-Based Oral Drug Delivery System for Peptide, Protein and Vaccine Delivery
- Nanoparticles as Drug Delivery Systems
- A Novel Drug Delivery System Based on Nanoparticles of Magnetite Fe<sub>3</sub>O<sub>4</sub> Embedded in an Auto Cross-Linked Chitosan